Statistics for Reply: 3,4-diaminopyridine in LEMS: Concerns regarding presentation of previous studies
Total visits
views | |
---|---|
Reply: 3,4-diaminopyridine in LEMS: Concerns regarding presentation of previous studies | 328 |
Total visits per month
views | |
---|---|
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
Sanders_2018_Reply.pdf | 418 |
java.util.UUID:1f01127d-2f55-4a9e-ba76-c6140092a98b | 62 |
java.util.UUID:78ab73a4-352b-4271-a7b5-2c24b0db9cfc | 11 |
java.util.UUID:264335ad-cc43-481f-9eda-edc4c95e2833 | 9 |
Top country views
views | |
---|---|
United States | 205 |
Germany | 12 |
Russia | 7 |
Sweden | 7 |
Ukraine | 7 |
United Kingdom | 5 |
China | 4 |
Canada | 2 |
France | 2 |
Curaçao | 1 |
Greece | 1 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 50 |
Fairfield | 30 |
Ann Arbor | 25 |
Houston | 17 |
Cambridge | 10 |
Kiez | 9 |
White Plains | 9 |
Jacksonville | 7 |
Kiev | 7 |
Stockholm | 7 |
Baltimore | 3 |
Moscow | 3 |
Saint Petersburg | 3 |
Warrington | 3 |
Guangzhou | 2 |
Iowa City | 2 |
Lake Mary | 2 |
Nanterre | 2 |
Raleigh | 2 |
San Francisco | 2 |
Toronto | 2 |
Washington | 2 |
Athens | 1 |
Beijing | 1 |
Brooklyn | 1 |
Gunzenhausen | 1 |
Hürth | 1 |
Liversedge | 1 |
Munich | 1 |
Overland Park | 1 |
Philadelphia | 1 |
Scottsdale | 1 |
Seremban | 1 |
Zheleznogorsk | 1 |